Healthcare Analytics, Population Health Management, Healthcare Big Data

Genomics

Genomics, Clinical Decision Support Combo Cuts ED Visits by 42%

February 8, 2017 - Providers who combined genetic testing with a clinical decision support tool to treat home health patients using multiple medications were able to reduce hospital readmissions by 52 percent and cut ED visits by 42 percent, according to a study published in PLOS ONE. The study, conducted by researchers from Harding University and Unity Health-White County Medical Center, also found that conducting...


More Articles

Genomics, Clinical Decision Support Combo Cuts ED Visits by 42%

by Jennifer Bresnick

Providers who combined genetic testing with a clinical decision support tool to treat home health patients using multiple medications were able to reduce hospital readmissions by 52 percent and cut ED visits by 42 percent, according to a study...

NIH Renames Precision Medicine Cohort, Urges Patient Engagement

by Thomas Beaton

The newly unveiled All of Us Research Program, formally known as the Precision Medicine Initiative (PMI) Cohort, will help the NIH collect diverse patient data and foster patient engagement to support its million-member precision medicine biobank....

NIH Awards $21M to Precision Medicine Epilepsy Collaboration

by Jennifer Bresnick

An international academic research consortium will use precision medicine strategies and a new $21 million grant from the National Institutes of Health to further research into the development and treatment of epilepsy. The collaboration, spearheaded...

Precision Medicine Benefits Pediatric Cancer Care, Study Says

by Thomas Beaton

Investigators at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center found that precision medicine can be used to diagnose genetic abnormalities and properly treat patients with pediatric brain cancers. By testing tumor samples,...

Northwell Health Launches Precision Medicine, Cancer Biobank

by Thomas Beaton

Northwell Health and Indivumed are creating a new patient biobank to help expand opportunities for cancer research and the development of precision medicine therapies. In the three-year agreement announced in a press release this week, Northwell...

Cancer Research Orgs Release Big Data for Precision Medicine

by Jennifer Bresnick

The American Association for Cancer Research (AACR) is releasing more than 19,000 de-identified genomic records to further the international research community’s explorations into precision medicine.  The big data dump, which includes...

IBM Watson, Mount Sinai Launch New Precision Medicine Projects

by Jennifer Bresnick

Precision medicine partnerships are becoming all the rage as public and private healthcare organizations pool their expertise and resources to overcome the challenges of developing personalized treatments for cancer and other diseases. Some familiar...

Precision Medicine Partnerships Foster Promises of Breakthroughs

by Jennifer Bresnick

Precision medicine projects, partnerships, and collaborations are continuing to proliferate as providers, research organizations, and vendors look to capitalize on the growing enthusiasm for integrating genomics and personalized insights into...

API-Based Genomics Databank Facilitates Personalized Medicine

by Jennifer Bresnick

Genomic testing is becoming an increasingly common starting place for the development of personalized medicine treatments for patients with a variety of hard-to-treat diseases, especially cancer, but organizations often struggle with interpreting...

Cancer Moonshot Report Showcases Precision Medicine Progress

by Jennifer Bresnick

The Cancer Moonshot has made significant progress since its January launch, bringing together public and private precision medicine organizations in one of the largest concerted efforts to tackle the deadly disease, said Vice President Joe Biden...

FDA Holds App-a-Thon for Precision Medicine, Next-Gen Genomics

by Nathan Boroyan

The FDA is hosting an industry-wide development challenge to create apps that use next-generation sequencing (NSG) technology to pursue new precision medicine breakthroughs. “FDA is increasingly harnessing the power of supercomputers, the...

Precision Medicine, Genomics Partnership Boosts Big Data Sharing

by Nathan Boroyan

The Multiple Myeloma Research Foundation will contribute genomic and clinical data to the Genomic Data Commons, one of the National Cancer Institute’s centerpiece precision medicine projects, the organizations announced last week. The Genomic...

Big Data Integrity Needed to Use Genomics for Care Coordination

by Jennifer Bresnick

Genomics is the cornerstone of the cutting-edge precision medicine programs aimed at eradicating cancer and other high-impact diseases, but it can also have a significant impact on improving more generalized patient outcomes.  A new...

29% of Healthcare Providers Currently Use Precision Medicine

by Jennifer Bresnick

Close to a third of healthcare organizations participating in a HIMSS Analytics poll are currently employing precision medicine techniques in everyday care, indicating that a personalized approach to medicine is already much more than just a...

VA, DOD, NCI Partner for Precision Medicine Tumor Screening

by Nathan Boroyan

A new precision medicine partnership between the Department of Veterans Affairs (VA), the Department of Defense (DoD) and the National Cancer Institute (NCI) will create the nation's first system that routinely screens tumors for gene and...

Despite Possibilities of Precision Medicine, Challenges Remain

by Nathan Boroyan

Precision medicine is an emerging approach to disease treatment and prevention that takes into account each person's genes, environment, and lifestyle. The ideas behind precision medicine are not new, but the development of big data analytics,...

Is Gene Therapy a False Trail for Precision Medicine Research?

by Jennifer Bresnick

Gene therapy researchers aiming to create precision medicine treatments may be heading in the wrong direction, according to an editorial published last month in the Journal of the American Medical Association, and should not be the only areas...

Precision Medicine Study Highlights Role of Machine Learning

by Nathan Boroyan

When it comes to the future of diagnosing and treating cancer, computers – not humans – could hold the key to delivering the best quality precision medicine. A new study out of the Stanford University School of Medicine has found...

Can IBM Watson Prove the Value of Precision Medicine in China?

by Jennifer Bresnick

Even as the Precision Medicine Initiative gears up in the United States, bringing with it a renewed effort to focus on a cure for cancer, IBM Watson has its sights set on even bigger goals for personalized care.  Today, the cognitive computing...

Google, Stanford Partner for Genomics, Precision Medicine Project

by Sara Heath

Stanford Medicine and Google are teaming up to build Stanford’s Clinical Genomics Service, which aims to leverage big data to improve precision medicine and patient care. According to a Stanford press release, the medical system will be...

Continue to site...